__NUXT_JSONP__("/drugs/Fresolimumab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"948564-73-6",chebiId:b,chemicalFormula:b,definition:"A pan-specific, recombinant, fully human monoclonal antibody directed against human transforming growth factor (TGF) -beta 1, 2 and 3 with potential antineoplastic activity. Fresolimumab binds to and inhibits the activity of all isoforms of TGF-beta, which may result in the inhibition of tumor cell growth, angiogenesis, and migration. TGF-beta, a cytokine often over-expressed in various malignancies, may play an important role in promoting the growth, progression, and migration of tumor cells.",fdaUniiCode:"375142VBIA",identifier:"C63546",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C129822","C20401"],synonyms:["Anti-TGF-Beta Monoclonal Antibody GC1008","FRESOLIMUMAB",a,"GC1008","Human Anti-TGF-Beta Monoclonal Antibody GC1008","Immunoglobulin G4, anti-(transforming growth factor beta) (human monoclonal GC-1008 heavy chain), disulfide with human monoclonal GC-1008 light chain, Dimer","anti-TGF-beta monoclonal antibody GC1008"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FFresolimumab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Fresolimumab","","2021-10-30T13:42:21.563Z")));